Didrogesteron influence on the pregnancy course and outcomes in patients with habitual miscarriage

Didrogesteron influence on the pregnancy course and outcomes in patients with habitual miscarriage

To determine the effect of dydrogesterone on the course and outcome of pregnancy in patients with recurrent pregnancy loss a prospective cohort study was conducted. It involved 702 women, divided into three groups according to their anamneses and I trimester therapy. The research showed that dydoges...

ver descrição completa

Detalhes bibliográficos
Autor principal:	M G Nikolaeva
Formato:	Artigo
Idioma:	Russian
Publicado em:	IP Berlin A.V. 2013-12-01
Colecção:	Гинекология
Assuntos:	habitual miscarriage dydrogesterone preeclampsia relative risk
Acesso em linha:	https://gynecology.orscience.ru/2079-5831/article/view/28282

Registos relacionados

The role of dydrogesterone in habitual miscarriage
Por: E. S. Polushkina, et al.
Publicado em: (2020-04-01)

Dydrogesterone in the treatment of the threatened and habitual miscarriage
Por: N. K. Tetruashvili, et al.
Publicado em: (2018-09-01)

Pharmacotherapy with Using Vitamins and Minerals of Idiopathic Habitual Miscarriage
Por: Markin L., et al.
Publicado em: (2014-06-01)

Regarding the evidence-based use of micronized progesterone
Por: A. D. Makatsariya, et al.
Publicado em: (2020-11-01)

Chronic endometritis and habitual miscarriage
Por: I. B. Manukhin,, et al.
Publicado em: (2018-04-01)

ROLE OF POLYMORPHISM OF GENES OF THE ANTIOXIDANT SYSTEM ENZYMES IN THE HABITUAL MISCARRIAGE GENESIS
Por: K. V. Morozova, et al.
Publicado em: (2016-06-01)

Modern ideas about endometrial disorders with habitual miscarriage
Por: T. A. Bazieva, et al.
Publicado em: (2023-01-01)

Resolution of the I Ukrainian forum on miscarriages
Por: T.F. Tatarchuk, et al.
Publicado em: (2024-10-01)

The role of chronic endometritis in the aspect of habitual miscarriage in patients with adenomyosis
Por: E. I. Kravtsova, et al.
Publicado em: (2023-07-01)

Immunotherapy for recurrent miscarriage due to alloimmune reasons
Por: V A Saribegova, et al.
Publicado em: (2017-02-01)

Features of early pregnancy treatment in women with luteal phase defect
Por: A F Mikhelson, et al.
Publicado em: (2013-04-01)

Progestagens in high-risk pregnancy. What we know today
Por: N.Y. Pedachenko, et al.
Publicado em: (2023-06-01)

Effect of immunocytotherapy on the state of the immune system of women with idiopathic habitual miscarriage
Por: L. V. Krechetova, et al.
Publicado em: (2020-08-01)

Intrauterine hematomas as a reason of complicated pregnancy course
Por: I. V. Kuznetsova
Publicado em: (2016-12-01)

Bemiparin in the treatment of a patient with a habitual miscarriage
Por: N K Tetruashvili, et al.
Publicado em: (2017-10-01)

Effect of Dydrogesterone on Treatment of Threatened Miscarriage: A Systematic Review and Meta-Analyses
Por: Thitiporn Siriwachirachai, et al.
Publicado em: (2011-09-01)

Multigenic forms of thrombophilia in habitual miscarige
Por: Voronin K.V., et al.
Publicado em: (2015-03-01)

Multigenic forms of thrombophilia in habitual miscarige.
Por: K. V. Voronin, et al.
Publicado em: (2015-03-01)

Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis
Por: Kai Chen, et al.
Publicado em: (2023-06-01)

Outcome of art programs for patients with habitable inequality of pregnancy in anamnesis
Por: O E Korotchenko, et al.
Publicado em: (2017-12-01)

A systematic evaluation of recurrent miscarriage cases and associated risk factors - a hospital based observational study in North India
Por: Sukhbir Pal Kaur, et al.
Publicado em: (2022-02-01)

Oral dydrogesterone versus oral micronized progesterone in threatened miscarriage: protocol paper for a randomized controlled trial
Por: Alka Kriplani, et al.
Publicado em: (2025-02-01)

Cytokines and pregnancy complications: modulation for prevention and treatment
Por: Raj Raghupathy
Publicado em: (2022-06-01)

Efficacy and safety of gestogens in women with metabolic syndrome
Por: E I Borovkova
Publicado em: (2014-02-01)

Efficacy of oral versus vaginal progestogens for early pregnancy maintenance in women with recurrent miscarriages: a randomized controlled trial
Por: Laiyla Shinwari, et al.
Publicado em: (2024-03-01)

PROGNOSTIC VALUE OF IMMUNOLOGICAL AND GENETIC TESTING IN THE I TRIMESTER OF PREGNANCY COMPLICATED BY SUBCHORIONIC HEMATOMA
Por: M. V. Utrobin, et al.
Publicado em: (2017-09-01)

Endometriosis: impact on fertility and pregnancy outcomes
Por: Rushania I. Gabidullina, et al.
Publicado em: (2021-03-01)

The effect of body mass index on the outcome of pregnancy in women with recurrent miscarriage
Por: Winnie Lo, et al.
Publicado em: (2012-01-01)

Comparison of the effect of dydrogesterone and natural micronized progesterone for luteal‐phase support in assisted reproductive technology cycles: A single‐blind randomized clinical trial study
Por: Masoomeh Atarieh, et al.
Publicado em: (2024-08-01)

Pregnancy after miscarriage: Psychological implications and emotional care
Por: Diana-Antonia Iordachescu, et al.
Publicado em: (2021-12-01)

Modern methods of diagnosis and treatment of vaginal dysbiosis caused by mushrooms of the genus Candida
Por: Е. Н. Носенко, et al.
Publicado em: (2017-09-01)

Impact of Recurrent Miscarriage on Maternal Outcomes in Subsequent Pregnancy: The Mutaba’ah Study
Por: Ali N, et al.
Publicado em: (2020-12-01)

Effect of online problem-solving counseling on the sexual anxiety and intimacy of women with recurrent pregnancy loss: A clinical trial
Por: Shahla Mohammadkhani, et al.
Publicado em: (2024-11-01)

Didrogesteron use in multiple pregnancy
Por: I O Bushtyreva, et al.
Publicado em: (2015-02-01)

Ultrasound diagnostics of miscarriage in the first trimester of pregnancy
Por: Chekhonatskaya M.L., et al.
Publicado em: (2013-12-01)

Sporadic pregnancy loss and recurrent miscarriage
Por: A. Coomarasamy, et al.
Publicado em: (2020-12-01)

The prevalence of molar pregnancy among patients with incomplete miscarriage at a maternity teaching hospital
Por: Zheen Hazim Ali, et al.
Publicado em: (2024-04-01)

Incidence of anti-toxoplasma antibodies in women with high-risk pregnancy and habitual abortions
Por: Maria de la Luz Galvan Ramirez, et al.
Publicado em: (1995-12-01)

Lack of association between angiotensin converting enzyme I/D polymorphism and unexplained recurrent miscarriage in Saudi Arabia
Por: Al-Mukaynizi Fatimah Basil, et al.
Publicado em: (2016-01-01)

Analysis of the differentiation of peripheral B-lymphocytes in pregnant women with a habitual miscarriage
Por: N. Yu. Sotnikova, et al.
Publicado em: (2021-06-01)